4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-14-004820
$NBYCIK 0001389545operating
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 7:24 PM ET
Size
6.2 KB
Accession
0001437749-14-004820
Insider Transaction Report
Form 4
Dailley Anthony
Director
Transactions
- Exercise/Conversion
Option (right to buy)
2014-03-17−9,000→ 191,967 totalExercise: $0.56From: 2007-09-30Exp: 2014-05-01→ Common Stock (9,000 underlying) - Exercise/Conversion
Common Stock
2014-03-17$0.56/sh+9,000$5,040→ 285,259 total
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 7:24 PM ET
- Size
- 6.2 KB